All In Biotech

Drug Trial Radar · NCT05536752

QA102 Phase II Study in Subjects With Dry AMD

A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Efficacy of QA102 in Subjects With Dry Age-Related Macular Degeneration (AMD)

Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

150

Actual

Start

Sep 22, 2022

Primary completion

Nov 12, 2024

Study completion Nov 12, 2024

Sponsor

Lead sponsor
Smilebiotek Zhuhai LimitedIndustry
Sponsor type
Industry
First posted
Sep 13, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2, double-masked, randomized, placebo-controlled, dose-response study. The primary objective of the study is to evaluate the efficacy of QA102 oral capsules on the development of soft drusen, visual acuity (VA), and geographic atrophy (GA) or choroidal neovascularization (CNV) or the progression of GA in subjects with intermediate to advanced dry AMD.

Conditions

  • Dry Age-related Macular Degeneration

Interventions

  • QA102/PlaceboDrug

    Capsules

  • QA102Drug

    Capsules

  • PlaceboDrug

    Capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Soft Drusen Volume (mm3)Time frame: Month 12

Locations

29 sites in 1 country. Site status is shown where the registry gives one.

  • Associated Retina Consultants

    Phoenix, Arizona

  • Northern California Retina Vitreous Associates Medical Group

    Mountain View, California

  • California Eye Specialists Medical Group

    Pasadena, California

  • California Eye Specialists Medical Group

    Redlands, California

  • Retina Consultants of Southern Colorado, P.C.

    Colorado Springs, Colorado

  • Advanced Research

    Deerfield Beach, Florida

  • National Ophthalmic Research Institute

    Fort Myers, Florida

  • MedEye Associates

    Miami, Florida

  • Retina Specialty Institute

    Pensacola, Florida

  • Eye Associates of Pinellas

    Pinellas Park, Florida

  • Sarasota Retina Institute

    Sarasota, Florida

  • Vitreous and Retina Consultants

    Winter Haven, Florida

  • Marietta Eye Clinic

    Marietta, Georgia

  • University Retina and Macula Associates

    Oak Forest, Illinois

  • Northeast Louisiana dba Haik Humble Eye Center

    West Monroe, Louisiana

  • The Retina Care Center

    Baltimore, Maryland

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland

  • Mid Atlantic Retina Specialists

    Hagerstown, Maryland

  • Vitreo-Retinal Associates, P.C.

    Worcester, Massachusetts

  • Retina Research Institute

    St Louis, Missouri

  • Velocity Clinical Research

    Cincinnati, Ohio

  • Verum Research, LLC

    Eugene, Oregon

  • Erie Retina Research

    Erie, Pennsylvania

  • Retina Research Institute of Texas

    Abilene, Texas

  • Austin Research Center for Retina

    Austin, Texas

  • AXIS Clinicals LLC / Retina of North Texas

    Dallas, Texas

  • Texas Retina Associates - Plano

    Plano, Texas

  • San Antonio Eye Center

    San Antonio, Texas

  • Rocky Mountain Retina Consultants

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.